Coagulation Study Guide Flashcards
What is thrombocytopenia
when you have a reduction in your platelet count
What level of platelets is a patients considered thrombocytopenic
platelet count of below 150,000
Spontaneous bleeding platelet count
less than 20,000
prolonged bleeding platelet count
less than 50,000
clinical manifestations of thrombocytopenia
Bruising, petechia, purpura, gingival bleeding, epitaxies (nose bleeds), pain/tenderness
assessment of a thrombocytopenia patient
Assess skin, patient tolerance, signs and symptoms of bleeding
DX studies for Thrombocytopenia
- Platelet count: less than 150,000
- ITP antigen specific assay to rule out
- PF4 heparin complex to rule out TTP
- increased LDH for TTP
- bone marrow examination: to rule out leukemias or anemais
plan of care for thorombocytopenic patient
- Avoid aspirin or other thrombocytopenia drugs
- educate on signs of bleeding
- call provider if nosebleed is longer than 10 minutes
- avoid IM injections – use SQ since it is a smaller needle and hold pressure for 5-10 minutes after
- women: menstrual loss: count the sanitary pads
what is ITP
ITP is immune thrombocytopenic purpura which is an autoimmune disease where the antibodies coat the platelets causing the spleen to recognize them as foreign and then destroy them with macrophages.
contributors: H. Pylori or viral infection
how to treat ITP
- ITP is treated with corticosteroids like prednisone to help suppress the phagocytic response and to help depress the autoimmune antibodies.
- You can do IVIG if the patients are unresponsive to Option one.
- A splenectomy may be beneficial but if its chronic
- if they are unable to get one then they can take a thrombopoietin receptor a (romiplostim) to help increase platelet production.
- you can also have a platelet transfusion if less than 10,000 or there is anticipated bleeding before a procedure.
what is TTP
- Combination of thrombocytopenia and anemia.
- normally cells release Vwf which will stick to exposed fibers in the torn tissue and become glue like allowing the platelets to stick to the site.
- as the platelets pile on top of each-other they link together and form a clot
- In TTP there is a deficiency in the enzyme ADAMTS13 which would normally break down Vwf when it is no longer needed.
- without this regulation by ADAMST13, small clots can form more frequently in the body.
- These small clots formed block normal BF through arteries= decreased platelets and increased rbc destruction
-Bleeding and clotting at the same time
what is TTP
- Combination of thrombocytopenia and anemia.
- normally cells release Vwf which will stick to exposed fibers in the torn tissue and become glue like allowing the platelets to stick to the site.
- as the platelets pile on top of each-other they link together and form a clot
- In TTP there is a deficiency in the enzyme ADAMTS13 which would normally break down Vwf when it is no longer needed.
- without this regulation by ADAMST13, small clots can form more frequently in the body.
- These small clots formed block normal BF through arteries= decreased platelets and increased rbc destruction
-Bleeding and clotting at the same time because As the platelets clump together, fewer platelets are available in the blood in other parts of the body to help with clotting.
How is TTP treated
- treating the underlying cause or infection.
- Plasmapheresis
- corticosteroids
- immunosuppressive therapy (rituximab for refractory plasma exchange to block the inhibitory ADAMTS13 IgG antibodies
- administering platelets is contraindicated because they will just continue to clot together.
what is plasmapheresis
- a procedure in which blood is removed from the body, filtered through a device, and separated into its individual components.
- Some of the filtered blood components are removed, and the rest of the blood returns to the patient.
- It removes antibodies and cleans the blood.
What is HIT
- complication of heparin that causes Decreased platelets in the blood
- antibodies are created against Heparin because its binding to PF4
- Heparin binding to PF4 creates positive feedback loop encouraging other PF4 heparin complexes to form
- antibodies attach to PF4 + heparin complex which activates the platelets
- small clots form and deplete platelet count
- Antibodies will attack these complexes and remove the platelets prematurely
- all this leads to more and more platelets getting activated and they start making clots. but also remaining platelets will get consumed = low platelet count.
- widespread abnormal clots= risk for thrombotic events